Proteome Sciences plc (AIM:PRM)

London flag London · Delayed Price · Currency is GBP · Price in GBX
4.300
-0.140 (-3.15%)
Feb 14, 2025, 4:00 PM EST
-4.44%
Market Cap 13.31M
Revenue (ttm) 4.04M
Net Income (ttm) -4.08M
Shares Out 295.18M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 677,509
Average Volume 141,648
Open 4.000
Previous Close 4.440
Day's Range 4.000 - 4.575
52-Week Range n/a
Beta 0.19
RSI 62.44
Earnings Date Mar 31, 2025

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathw... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 1993
Employees 35
Stock Exchange London Stock Exchange AIM
Ticker Symbol PRM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.